While gurus are still holding stakes in these companies, the prices of the stocks and returns of the investors are dropping. These are the worst-performing stocks over the last six months that have a long-lasting presence in more than four gurus’ portfolio.
Key Energy Services Inc. (KEGX) reports a negative performance over the last three months with a price drop of 87.1%. Regardless of this, four mutual funds are holding the company with a total weight of 0.02% on their portfolios.
The company has a market cap of $12.88 million and is trading with a price-book (P/B) ratio of 0.22 and a price-sales (P/S) ratio of 0.01. The price of 8 cents is 46.7% below its 52-week high and 59.68% above its 52-week low; over the long term of 10 years it returned a loss of 99%.
Over the last five years, Key Energy Services has reported a decrease of 10.70% in its revenue.
Current returns are negative: Return on assets (ROA) is -54.89%, ranked lower than 90% of other competitors, and return on equity (ROE) is -193.63%, worse than 98% of other companies in the Global Oil & Gas Equipment & Services industry.
During the last quarter Arnold Van Den Berg (Trades, Portfolio) exited his position in this company.
Cross Country Healthcare Inc. (CCRN) reports a negative performance over the last three months with a price drop of 13.4%. Despite this, four mutual funds are holding the company with a total weight of 0.03% on their portfolios.
The company has a market cap of $412.31 million and is trading with a price-earnings (P/E) ratio of 89.30 and a forward P/E ratio of 20.66. The price of $12.50 is 33.37% below its 52-week high and 28.60% above its 52-week low; over the long term of 10 years it returned a loss of 20%.
Over the last five years, Cross Country Healthcare has reported a growth of 12.10% in its revenue.
Current returns are positive: ROA is 14.40%, ranked higher than 50% of other competitors, and ROE is 5.92%, worse than 56% of other companies in the Global Staffing & Outsourcing Services industry.
In recent quarters Jim Simons (Trades, Portfolio) and Joel Greenblatt (Trades, Portfolio) reduced their stakes while Paul Tudor Jones (Trades, Portfolio) and Steven Cohen (Trades, Portfolio) acquired new positions in the company.
LHC Group Inc. (LHCG) reports a negative performance over the last three months with a price drop of 7.0%. In spite of this, four mutual funds are holding the company with a total weight of 0.04% on their portfolios.
The company has a market cap of $719.6 million and is trading with a P/E ratio of 20.99 and a forward P/E ratio of 20.20. The price of $39.64 is 23.37% below its 52-week high and 20.96% above its 52-week low; over the long term of 10 years it returned a gain of 73%. According to the DCF calculator the company is overpriced by 93%.
Over the last five years, LHC Group has reported a gain of 6.30% in its revenue and 24.70% for its EBITDA.
Current returns are negative: ROA is -6.11%, higher than 61% of industry competitors, and ROE is -9.62%, worse than 51% of other companies in the Global Medical Care industry.
During the last quarter Jones acquired a new position in the company, and Simons raised his stake while Cohen and Greenblatt reduced their stakes.
Acorda Therapeutics Inc. (ACOR) reports a negative performance over the last three months with a price drop of 7.3%. Regardless of this, four mutual funds are holding the company with a total weight of 0.04% on their portfolios.
The company has a market cap of $1.11 billion and is trading with a P/B ratio of 1.66 and a P/S ratio of 2.06. The price of $23.99 is 45.01% below its 52-week high and 0.76% above its 52-week low; over the long term of 10 years it returned a gain of 610%.
Over the last five years, Acorda Therapeutics has reported a growth of 15.10% in its revenue.
Current returns are negative: ROA is -0.91%, ranked higher than 74% of other competitors, and ROE is -0.48%, better than 76% of other companies in the Global Biotechnology industry.
During the last quarter John Hussman (Trades, Portfolio) increased his stake, and Greenblatt and Jones acquired new positions in the company while Simons and Cohen reduced their stakes.
Movado Group Inc. (MOV) reports a negative performance over the last three months with a price drop of 17.7%. Despite this, four mutual funds are holding the company with a total weight of 0.06% on their portfolios.
The company has a market cap of $523.47 million and is trading with a P/E ratio of 11.92 and a P/S ratio of 0.90. The price of $22.75 is 26.57% below its 52-week high and 18.86% above its 52-week low; over the long term of 10 years it returned a gain of 3%. According to the DCF calculator the company is now overpriced by 11%.
Over the last five years, Movado Group has reported growth of 9.40% in its revenue, 63.70% in its EBITDA and 8.10% in its free cash flow.
Current returns are negative: ROA is -7.55%, ranked higher than 76% of its competitors, and ROE is -9.95%, better than 63% of other companies in the Global Luxury Goods industry.
During the last quarter Chuck Royce (Trades, Portfolio) and John Keeley (Trades, Portfolio) raised their stakes in the company, David Dreman (Trades, Portfolio), Simons and John Rogers (Trades, Portfolio) acquired new positions while Cohen, Murray Stahl (Trades, Portfolio), Greenblatt and Jones reduced their stakes.
MDC Partners Inc. Class A (MDCA) reports a negative performance over the last three months with a price drop of 17.6%. Despite this, four mutual funds are holding the company with a total weight of 0.06% on their portfolios.
The company has a market cap of $704.94 million and is trading with a P/S ratio of 0.50. The price of $13.18 is 44.85% below its 52-week high and 6.46% above its 52-week low; over the long term of 10 years it returned a gain of 139%.
Over the last five years, MDC Partners has reported a growth of 8.90% in its revenue while EPS decreased 14.20%.
Current returns are negative: ROA is -3.45%, ranked lower than 72% of other competitors, and ROC is 30.84%, worse than 53% of other companies in the Global Marketing Services industry.
During the last quarter Greenblatt reduced his stake in the company while Simons raised his stake, and Leon Cooperman (Trades, Portfolio) and Jones acquired new positions in the company.
Disclosure: I do not own any shares of any stocks mentioned in this article.
Start a free seven-day trial of Premium Membership to GuruFocus.
